Actively Recruiting
Long-term COVID and Rehabilitation
Led by VA Office of Research and Development · Updated on 2025-09-18
300
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The proposed focuses on improving both morbidity and mortality in older Veterans and those recovering from COVID-19 by developing rehabilitation therapies to augment vascular endothelial function by combating the oxidative stress and inflammation associated with aging and further induced by COVID-19. The investigators expected outcomes will have an important positive impact because they will provide scientifically sound recommendations for rehabilitation to improve vascular endothelial function and minimize the long-term consequences of COVID-19.
CONDITIONS
Official Title
Long-term COVID and Rehabilitation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 50 years of age or greater
- Long-COVID and COVID-recovered patients must have SARS-CoV-19 positive test near the time of COVID-19 diagnosis
- Long-COVID and COVID-recovered patients must be 3-12 months post-initial COVID-19 diagnosis
- Ability to sign informed consent
You will not qualify if you...
- Body mass index (BMI) greater than 45 kg/m2
- Unstable or severe coronary artery disease within the last 6 months
- Severe peripheral artery disease with Ankle Brachial Index less than 0.40
- Cerebrovascular disease such as stroke in the last 12 months
- Severe chronic obstructive pulmonary disease (Stage III)
- Uncontrolled hypertension above 160/100 mmHg
- Chronic kidney disease requiring dialysis or severe renal insufficiency (creatinine clearance less than 30)
- Alzheimer's disease or dementia
- Orthopedic limitations preventing exercise
- Current smokers or those who stopped smoking within the last 10 years
- Already taking Mitoquinone (Mito-Q) or unwilling to stop dietary supplements for participation
- Any other condition or event deemed exclusionary by the principal investigators or a physician
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
VA Salt Lake City Health Care System, Salt Lake City, UT
Salt Lake City, Utah, United States, 84148-0001
Actively Recruiting
Research Team
J
Joel D Trinity, PhD
CONTACT
R
Russell S Richardson, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here